Finding chemopreventatives to reduce amyloid beta in yeast
Neural Regeneration Research, ISSN: 1876-7958, Vol: 11, Issue: 2, Page: 244-245
2016
- 4Citations
- 128Usage
- 13Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations4
- Citation Indexes4
- CrossRef4
- Usage128
- Downloads122
- Abstract Views6
- Captures13
- Readers13
- 13
Article Description
Alzheimer's disease (AD) is the most common form of age-related dementia with the latest report (WorldAlzheimerReport, 2015) showing 46.8 million people are currently affected by dementia. That number is expected to double every 20 years unless there is effective therapeutic intervention.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84962591368&origin=inward; http://dx.doi.org/10.4103/1673-5374.177729; http://www.ncbi.nlm.nih.gov/pubmed/27073375; https://journals.lww.com/10.4103/1673-5374.177729; https://ro.ecu.edu.au/ecuworkspost2013/1851; https://ro.ecu.edu.au/cgi/viewcontent.cgi?article=2855&context=ecuworkspost2013; https://dx.doi.org/10.4103/1673-5374.177729; https://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=2;spage=244;epage=245;aulast=Macreadie; http://sciencechina.cn/gw.jsp?action=cited_outline.jsp&type=1&id=5656439&internal_id=5656439&from=elsevier; http://ro.ecu.edu.au/ecuworkspost2013/1851; http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=2;spage=244;epage=245;aulast=Macreadie
Medknow
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know